Dr. Alan Kersey has been engaged in sensor and instrumentation technology research and commercialization for the past 35 years. His research work began in 1981 at the University of Kent, which was followed by a 14 year tenure at the Naval Research Laboratory (NRL) in Washington DC. At NRL his focus on advanced fiber optic based sensing concepts, led to some of the seminal research on Bragg grating sensor systems.
In 1997, Alan joined a start-up, CiDRA, as the founding Chief Technology Officer, to develop fiber Bragg grating sensors for the Oil & Gas industry. He served on CiDRA's board from 2001 to 2003. From 2003 he was CEO of CyVera, a spin-out from CiDRA which developed a genetic analysis/assay platform – BeadXpress, which was acquired by the leading genetic sequencing company, Illumina in 2005. Following this acquisition, Alan was VP & General Manager of Illumina’s sequencing acquisition, Solexa, based in Cambridge, UK. From 2011 thru 2015, he re-joined CiDRA in an M&A role, to bring new sensor technologies to the suite the company has already developed & successfully deployed in industrial applications.
Currently Alan serves as the Chairman of ReadyDock, a company developing UV based disinfection systems for medical applications and as a Director on the Board of Industrial Tomography Systems (ITS) in the UK, a company that develops state of the art process control systems. He is also as a member of the Technical Advisory Boards of Insight Photonics, and Taff Optical. He is also currently engaged in the formation of several new biotech start-ups in Connecticut under a new entity Cycle Venture Partners.
Alan holds a B.Sc in Physics & Electronics at the University of Warwick, and a Ph.D. from the University of Leeds, UK. He is a Fellow of the Optical Society of America, has published extensively in journal and conference forums, and holds over 100 patents..